At Nouvelle Clinical Research we're dedicated to improving lives through innovative research. Our dedicated team provides personalized care and support throughout your participation.
Find out if you’re eligible to join one of our current studies and contribute to better treatments for tomorrow. Your participation matters.
This study investigates if inhaled COPD medicines can also protect you from serious heart events, such as heart attacks and heart failure, as well as reducing COPD flare- ups.
COMPENSATION UP TO: $1,400
This study investigates that correcting iron deficiency in patients with heart failure may increase resistance or resilience to a broad range of problems that cause hospitalizations.
COMPENSATION UP TO: TBD
This study evaluates whether investigational treatments (REGN7508 and REGN9933) may reduce the risk of bleeding events compared to apixaban in patients with atrial fibrillation. The goal is to improve safety outcomes while effectively managing AFib.
COMPENSATION UP TO: $1,000
This study evaluates the efficacy and safety of tezepelumab in adults with moderate to very severe COPD. The goal is to reduce exacerbations and improve respiratory outcomes in patients with a history of disease worsening.
COMPENSATION UP TO: $3,600